Antengene To Present One Oral and Four Abstracts at ASCO 2024
/PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated...
Source: prnewswire.com
Publication Only News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Publication Only. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Publication Only Today - Breaking & Trending Today
OSE Immunotherapeutics SA: OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi at the ASCO 2023 Annual Meeting
Tedopi is the Company's Most Advanced Product in Clinical Development ATALANTE-1, a Phase 3 clinical trial with positive results comparing Tedopi to chemotherapy in non-small cell lung cancer
Source: finanznachrichten.de
Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data on DecisionDx®-Melanoma and DecisionDx®-UM will be shared... | June 3, 2023
Source: marketscreener.com
Genprex Publishes Positive Clinical Data from Phase 1 Portion of Acclaim-1 Clinical Trial Evaluating REQORSA® Immunogene Therapy in Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...
Source: prnewswire.com
Servier to Showcase Growing Oncology Portfolio at the ASCO and EHA 2022 Annual Meetings
Wide range of research across tumor types underscores Servier's commitment to discovering novel approaches to addressing difficult-to-treat cancers Phase 3...
Source: prnewswire.com